February 11, 2019 Pharmacy Benefits Management Program - Federal Upper Payment Limits and Physician-Administered Drugs Reimbursement LAC 50:XXIX.105 and 949

Back to Main Notices of Intent Page

Back to Rulemaking Home Page

Amends the provisions governing reimbursement in the Pharmacy Benefits Management Program in order to: 1) reinstate the federal upper payment limits provisions that were erroneously repealed in the Notice of Intent published in the January 20, 2019 edition of the Louisiana Register; 2) align the reimbursement methodology for physician-administered drugs in a physician office setting with the corresponding CMS-approved State Plan Amendment; and 3) ensure that these provisions are appropriately promulgated in the Louisiana Administrative Code.

Contact Information:  Jen Steele, Bureau of Health Services Financing, P.O. Box 91030, Baton Rouge, LA 70821-9030

 .Act 401 Compliance:  The Notices of Intent pages were developed in accordance with ACT 401 of the 2014 Louisiana Legislative Session.

Disclaimer:  Please note that the official versions of the Notices of Intent are maintained by the Office of State Register’s website at http://www.doa.louisiana.gov/osr/osr.htm.  The excerpted versions of these Notices of Intent contained on this website are provided as a courtesy service to the public and is unofficial and should not be regarded as such. Users are encouraged to visit the Office of State Register’s website for the official version.

RELATED ITEMS

• Emergency Rule: N/A
• Notice of Intent: Prior to Proposed Rule: December 2018 LAC
• Notice of Intent: Proposed Rule
• Notice of Intent: February 20, 2019 (Louisiana Register)